Triangular Relationship between p53, Autophagy, and Chemotherapy Resistance

Area of Science:

• Oncology
• Molecular Biology
• Cellular Biology

Background:

• Chemotherapy and radiation trigger cellular responses like apoptosis, autophagy, and senescence.
• The tumor suppressor p53 is a key regulator of these processes, often mutated in cancer.
• Gain-of-function (GOF) p53 mutations can promote drug resistance by affecting p53's tumor-suppressive functions and modulating autophagy.

Purpose of the Study:

• To explore the complex relationship between p53 and autophagy in the context of cancer therapy.
• To investigate how p53's function and localization influence autophagy and drug resistance.
• To highlight the potential of targeting the p53-autophagy axis for novel cancer treatment strategies.

Main Methods:

• Review of pre-clinical studies on p53, autophagy, and chemotherapy response.
• Analysis of the role of p53 mutations and compartmentalization in modulating autophagy.
• Examination of evidence linking p53-autophagy interactions to drug resistance.

Main Results:

• Autophagy is initially induced by cancer therapies but has multifaceted roles, including promoting survival.
• p53's function, including GOF mutations, significantly impacts autophagy induction and inhibition.
• Compartmental localization of p53 influences autophagic processes and potentially tumor response.

Conclusions:

• The dual role of p53 and its effects on autophagy are critical factors in tumor response to therapy and drug resistance.
• Current clinical trial designs may not fully account for the complex p53-autophagy interplay.
• Further research into this interconnection could yield new insights for overcoming multidrug resistance and developing chemosensitization strategies.